Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency KEL Library | On Loan, due Monday, June 17, 2024 | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | On Loan, due Monday, June 3, 2024 | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency SUR Library | Available |
Contents:; 1: Basis of Carcinogenesis; 2: Epidemiology and Prevention; 3: Evidence-Based Nursing in Basic Anticancer Treatment: Management of the Most Important Side Effects; 4: The Patients? Journey with Targeted Therapies; 5: Immunotherapy: New Challenges for Nursing; 6: Robotic Surgery; 7: Relat…
Table of Contents:; 1. HISTORY OF IMMUNOTHERAPY -- 2. PRINCIPLES OF IMMUNOLOGY AND IMMUNOTHERAPY -- 3. CYTOKINES IN IMMUNOTHERAPY -- 4. IMMUNE CHECKPOINT INHIBITORS -- 5. BACILLUS CALMETTE-GUÉRIN - 6. ORAL IMMUNOMODULATORY AGENTS --7. ACTIVE IMMUNITY: VACCINE THERAPY -- 8. PASSIVE/ADOPTIVE IMMUNOTH…
c.1 BC Cancer Agency KEL Library | Available |
Table of Contents:; 1. Immunotherapy administration; 2. Immunotherapy; 3. Cancer immunotherapy; 4. CAR T-cell therapy; 5. Cytokine release syndrome; 6. Developming infrastructure; 7. Immunotherapy toxicities; 8. Checkpoint inhibitors; 9. Toxicity managment; 10.Oncolytic viruses
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VIC Library | Available |
Table of Contents:; 1 Biology of Cancer -- 2 Staging and Performance Status -- 3 Cancer Epidemiology and Prevention -- 4 Genetic Risk for Developing Cancer -- 5 Cancer Detection Measures -- 6 Pharmacogenomics -- 7 Surgery -- 8 Radiation Therapy -- 9 Chemotherapy -- 10 Precision Medicine: Biologics …
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
Table of Contents:; Cancer prevention, screening, and early detection -- Genetic risk -- Cancer diagnosis and staging -- Chemotherapy, targeted biotherapy, and molecular therapy -- Surgery -- Radiation therapy -- Blood and marrow stem cell transplantation -- Complementary and integrative therapies …